Company Name | Daiichi Sankyo, Inc. |
---|---|
Website | https://www.daiichisankyo.com |
Snippet | The Daiichi Sankyo group is actively engaged in various measures and initiatives such as, but not limited to, contributing to vaccination and drug research and development, ensuring a continuous supply of the Daiichi Sankyo group products, and providing disaster relief supports. |
Type | Public KK |
Founded | 2005 |
Revenue | $ 12.006 billion USD (FY 2012) (¥ 997.852 billion JPY) (FY 2012) |
Website | http://www.daiichisankyo.com |
Industry | Pharmaceutical |
Products | Medical equipment, Pharmaceutical products, Veterinary medicines |
Traded as | TYO: 4568TOPIX Large 70 ComponentTOPIX 100 ComponentNikkei 225 Component |
Key people | Sunao Manabe (Representative Director, CEO and President)[1][2] |
Net income | $ 0.801 billion USD (FY 2012) (¥ 66.621 billion JPY) (FY 2012) |
Native name | 第一三共株式会社 |
Headquarters | Daiichi Sankyo Building A/B 3-5-1, Nihonbashi-honcho, Chūō-ku, Tokyo 103-8426, Japan |
Predecessors | Daiichi Pharmaceutical Company, Sankyo Company |
Romanized name | Daiichi Sankyō kabushiki gaisha |
Number of employees | 32,229 (as of December 2013) |
Daiichi Sankyo, Inc. is part of the Japan company list
Have a list of company names and need to update information? Use our Company Search tool.
Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.
Want to update this profile? Please contact us here with a link to the public source verifying the edit.
Powrbot Inc. is a passionate company working on problems using data analytics, automation & machine learning. Our goal is to automate the boring stuff.
Contact Us